Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Xi ZX, Song R, Li X, Lu GY, Peng XQ, He Y, Bi GH, Sheng SP, Yang HJ, Zhang H, Li J, Froimowitz M, Gardner EL.

Neuropsychopharmacology. 2017 Feb;42(3):682-694. doi: 10.1038/npp.2016.155. Epub 2016 Aug 18.

2.

Solution- and solid-state conformations of C(α)-alkyl analogues of methylphenidate (Ritalin) salts: avoidance of gauche(+)gauche(-) interactions.

Steinberg A, Froimowitz M, Parrish DA, Deschamps JR, Glaser R.

J Org Chem. 2011 Nov 18;76(22):9239-45. doi: 10.1021/jo201415h. Epub 2011 Oct 14.

PMID:
21973080
3.

Atypical diffusion tensor hemispheric asymmetry in autism.

Lange N, Dubray MB, Lee JE, Froimowitz MP, Froehlich A, Adluru N, Wright B, Ravichandran C, Fletcher PT, Bigler ED, Alexander AL, Lainhart JE.

Autism Res. 2010 Dec;3(6):350-8. doi: 10.1002/aur.162. Epub 2010 Dec 2.

4.

Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.

Peng XQ, Xi ZX, Li X, Spiller K, Li J, Chun L, Wu KM, Froimowitz M, Gardner EL.

Neuropsychopharmacology. 2010 Dec;35(13):2564-78. doi: 10.1038/npp.2010.133. Epub 2010 Sep 8.

5.

Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ, Froimowitz MP, Hassinger LC, Menesale EB, Sargent LW, Logan DJ, Carpenter AE, Cohen BM.

Am J Pathol. 2010 Aug;177(2):575-85. doi: 10.2353/ajpath.2010.081068. Epub 2010 Jun 21.

6.

Associations between IQ, total and regional brain volumes, and demography in a large normative sample of healthy children and adolescents.

Lange N, Froimowitz MP, Bigler ED, Lainhart JE; Brain Development Cooperative Group.

Dev Neuropsychol. 2010;35(3):296-317. doi: 10.1080/87565641003696833.

7.

Age-related changes in brain energetics and phospholipid metabolism.

Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM.

NMR Biomed. 2010 Apr;23(3):242-50. doi: 10.1002/nbm.1444.

PMID:
19908224
8.

Decreased left posterior insular activity during auditory language in autism.

Anderson JS, Lange N, Froehlich A, DuBray MB, Druzgal TJ, Froimowitz MP, Alexander AL, Bigler ED, Lainhart JE.

AJNR Am J Neuroradiol. 2010 Jan;31(1):131-9. doi: 10.3174/ajnr.A1789. Epub 2009 Sep 12.

9.

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT.

Mol Psychiatry. 2009 Jul;14(7):719-27. doi: 10.1038/mp.2008.130. Epub 2008 Dec 9. Erratum in: Mol Psychiatry. 2010 Nov;15(11):1122.

10.

Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.

J Med Chem. 2007 Jan 25;50(2):219-32.

PMID:
17228864
11.

A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: effects in laboratory rat models relating to addiction.

Gardner EL, Liu X, Paredes W, Giordano A, Spector J, Lepore M, Wu KM, Froimowitz M.

Neuropharmacology. 2006 Oct;51(5):993-1003. Epub 2006 Aug 8.

PMID:
16901516
12.

Vinylogous amide analogs of methylphenidate.

Froimowitz M, Gu Y, Dakin LA, Kelley CJ, Parrish D, Deschamps JR.

Bioorg Med Chem Lett. 2005 Jun 15;15(12):3044-7.

PMID:
15908207
13.

Automated identification of Fos expression.

Young D, Ma J, Cherkerzian S, Froimowitz MP, Ennulat DJ, Cohen BM, Evans ML, Lange N.

Biostatistics. 2001 Sep;2(3):351-64.

PMID:
12933544
14.

Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.

Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL.

J Med Chem. 2000 Dec 28;43(26):4981-92.

PMID:
11150168
15.
16.
17.

Activation of midline thalamic nuclei by antipsychotic drugs.

Cohen BM, Wan W, Froimowitz MP, Ennulat DJ, Cherkerzian S, Konieczna H.

Psychopharmacology (Berl). 1998 Jan;135(1):37-43.

PMID:
9489932
18.
19.
20.

Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophores.

Froimowitz M, Deng Y, Jacob JN, Li N, Cody V.

Drug Des Discov. 1995 Aug;13(1):73-81.

PMID:
8882902
21.

Absolute configurations and conformations of the opioid agonist and antagonist enantiomers of picenadol.

Froimowitz M, Cody V.

Chirality. 1995;7(7):518-25. Erratum in: Chirality 1996;8(4):352.

PMID:
7495643
22.

Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.

Teeter MM, Froimowitz M, Stec B, DuRand CJ.

J Med Chem. 1994 Sep 2;37(18):2874-88.

PMID:
7915325
23.

Chiral resolution of 1,3-dimethyl-4-phenylpiperidine derivatives using high-performance liquid chromatography with a chiral stationary phase.

Yin D, Khanolkar AD, Makriyannis A, Froimowitz M.

J Chromatogr A. 1994 Aug 26;678(1):176-9.

PMID:
7921191
26.

HyperChem: a software package for computational chemistry and molecular modeling.

Froimowitz M.

Biotechniques. 1993 Jun;14(6):1010-3. No abstract available.

PMID:
8333944
27.

The pharmacophore for opioid activity.

Froimowitz M.

NIDA Res Monogr. 1993;134:178-94. Review. No abstract available.

PMID:
8289878
28.
29.
30.

Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.

Froimowitz M, Pick CG, Pasternak GW.

J Med Chem. 1992 May 1;35(9):1521-5.

PMID:
1315868
31.
32.
33.

The development of computer simulations of the geometries and thermodynamics of biological molecules.

Froimowitz M.

Biotechniques. 1990 Jun;8(6):640-4, 649-52. Review.

PMID:
2192742
34.
35.

Conformational search in enkephalin analogues containing a disulfide bond.

Froimowitz M.

Biopolymers. 1990;30(11-12):1011-25.

PMID:
2081263
36.

Conformational analysis of enkephalin analogs containing a disulfide bond. Models for delta- and mu-receptor opioid agonists.

Froimowitz M, Hruby VJ.

Int J Pept Protein Res. 1989 Aug;34(2):88-96. Erratum in: Int J Pept Protein Res 1989 Oct;34(4):352.

PMID:
2553632
37.

Biologically active conformer for fentanyl and its derivatives.

Froimowitz M.

NIDA Res Monogr. 1989;95:302-3. No abstract available.

PMID:
2640974
38.

Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: evidence for different stereoselectivities at D1 and D2 receptors in rat brain.

Svendsen CN, Froimowitz M, Hrbek C, Campbell A, Kula N, Baldessarini RJ, Cohen BM, Babb S, Teicher MH, Bird ED.

Neuropharmacology. 1988 Nov;27(11):1117-24.

PMID:
2849726
39.

Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.

Neumeyer JL, Froimowitz M, Baldessarini RJ, Campbell A, Gao YG.

J Recept Res. 1988;8(1-4):83-96.

PMID:
3385694
40.
41.
42.

A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.

Froimowitz M, Neumeyer JL, Baldessarini RJ.

J Med Chem. 1986 Sep;29(9):1570-3. No abstract available.

PMID:
3746808
43.

Geometrical correspondence between phenazocine and the enkephalins.

Froimowitz M, Matthysse S.

J Med Chem. 1986 Apr;29(4):573-8.

PMID:
3007761
44.
45.
46.

Conformation-activity study of 4-phenylpiperidine analgesics.

Froimowitz M.

J Med Chem. 1982 Oct;25(10):1127-33.

PMID:
7143349
47.

Conformation-activity study of methadone and related compounds.

Froimowitz M.

J Med Chem. 1982 Jun;25(6):689-96. No abstract available.

PMID:
7097722
48.

Conformational energies and geometries of narcotics, using a potential function method.

Froimowitz M.

NIDA Res Monogr. 1978;(22):359-73. No abstract available.

PMID:
30910
49.

Prediction of the secondary structure of proteins using the helix-coil transition theory.

Froimowitz M, Fasman GD.

Macromolecules. 1974 Sep-Oct;7(5):583-9. No abstract available.

PMID:
4371089
50.

Conformation of 2,3-diformylglycerol, a model compound of membrane phospholipids.

Kang S, Froimowitz M, Hankins D.

J Theor Biol. 1974 Apr;44(2):337-47. No abstract available.

PMID:
4829238

Supplemental Content

Loading ...
Support Center